Start
Entdecken
nav.journalClub
Trends
Mehr
synapse
⌘+K
Sprache
Deutsch
Deutsch
De novo transcriptome sequencing of Artemisia absinthium predicted anti-SARS-CoV2 (COVID-19) bioactive secondary metabolites | Synapse
March 3, 2026
De novo transcriptome sequencing of Artemisia absinthium predicted anti-SARS-CoV2 (COVID-19) bioactive secondary metabolites
UK
Umar Khitab Khan
AA
Awais ALi
Abdul Wali Khan University Mardan
CL
Chunhua Li
Chinese Academy of Sciences
See all
Key Points
Bioactive secondary metabolites predicted to inhibit SARS-CoV2 have been identified.
Key evidence includes specific metabolites associated with antiviral activity against COVID-19.
Analysis focuses on de novo transcriptome sequencing of Artemisia absinthium to discover new compounds.
These findings may highlight new avenues for COVID-19 treatment and herbal medicine applications.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Khan et al. (Wed,) studied this question.
synapsesocial.com/papers/69a75d4fc6e9836116a271db
https://doi.org/https://doi.org/10.1007/s44473-025-00029-w